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or inherited disease, or as a result of
iatrogenic transmission. Prion dis-
eases generated great public concern
after an outbreak of bovine spongi-
form encephalopathy occurred in
many European countries and scien-
tific evidence indicated its transmis-
sion to humans.
Research in prion diseases is ham-
pered by certain unconventional prop-
erties of the presumed etiologic agent
and the long incubation period associ-
ated with these diseases. Most con-
ventional laboratory methods used to
study viruses and bacteria may not be
applicable. In the past, the etiologic
agent of transmissible spongiform
encephalopathies was believed to be a
slow virus, primarily because of its
transmissibility, ability to retain infec-
tivity after filtration, and long incuba-
tion period. The successful transmis-
sion of scrapie, a centuries-old prion
disease of sheep, to mice in 1961
greatly facilitated identification and
characterization of the scrapie agent.
Several characteristics of the scrapie
agent suggest that the agent is not a
virus but is likely composed primarily
of a protein. The agent’s characteris-
tics include the absence of disease-
specific nucleic acids; resistance to
radiation, nucleases, and standard
sterilization and disinfection methods;
and inactivation by protein-modifying
procedures. These observations and
purification of the scrapie prion in the
early 1980s led to widespread accept-
ance of the prion hypothesis.
Since the 1980s, both the scope
and nature of prion disease research
has progressed rapidly. The economic
and human cost associated with the
bovine spongiform encephalopathy
outbreak fueled the need to better
understand the etiologic agent of
prion diseases and their basic trans-
mission mechanism. Prions and Prion
Diseases: Current Perspectives sum-
marizes the advances in prion disease
research. It expands on a previous
volume edited by David Harris that
was published in 1999 under the title
Prions: Molecular and Cellular
Biology. The book’s 10 chapters
describe the biochemical and molecu-
lar features of prions and the normal
prion protein, various laboratory
methods for studying prions, and
advances in the pathogenesis and
immunology of prion diseases.
Chapters 2 through 6 detail labora-
tory methods developed to study the
unconventional agent of prion dis-
eases. Chapter 2 describes a cell-free
conversion reaction system to study
how pathogenic prions associated
with different species interact with
host cellular prion protein. Such sys-
tems have been used to study the bio-
chemical mechanisms of prion dis-
eases and can potentially be used to
screen new therapies for their effec-
tiveness against prion diseases.
Chapter 3 describes the mechanisms
underlying the biosynthesis and cell
biology of the cellular prion protein
by using cell culture systems.
Understanding the detailed biochemi-
cal properties of the cellular prion
protein will help show the molecular
basis of its interaction with, and con-
version to, the pathogenic prions.
Subsequent chapters in the book
describe other laboratory methods,
including transgenic mouse models,
which can be used to investigate the
transmissibility of prions among dif-
ferent species, the extent and degree
of the “species barrier,” the mecha-
nism of prion propagation, and prion
disease pathogenesis.
Overall, the book provides a
wealth of information on the progress
made in understanding the molecular,
immunologic, and genetic aspects of
prion diseases and the laboratory
methods used to study them. This
book will be valuable to prion disease
researchers, to scientists who want to
gain more knowledge about the
progress made in understanding the
mechanisms of prion propagation, and
to persons just beginning to study
these unconventional, fatal brain dis-
eases.
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Veterinary institutions help
improve animal health by providing
training that will enhance livestock
production and trade and protect pub-
lic health. The increasing role of ani-
mals in emerging infectious diseases
has emphasized the need to improve
veterinary services and integrate them
with public health services more
effectively. 
The World Organisation for
Animal Health devoted its Scientific
and Technical Review (Volume 23,
No. 1, April, 2004) to addressing
these weaknesses and the rapidly
changing environment of veterinary
services in developing countries. The
issue consisted of an introduction and
summary by the coordinator and con-
tributions from 28 persons organized
into six sections. The first sectionBOOK REVIEWS
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examines the relative roles of the pub-
lic and private sectors and included
two papers on economic frameworks
and two papers on technical experi-
ences in providing public services by
the private sector. A second section
emphasizes changing international
sanitary and phytosanitary regulations
and how veterinary services could
help meet these new requirements.
The third, fourth, and fifth sections
detail experiences in providing servic-
es across the developing world. The
most common experiences include
using paraprofessional staff, provid-
ing public services by the private sec-
tor, conducting surveillance, and
monitoring and controlling infectious
diseases. A final section explores
anticipated financial and institutional
capacity, research, and professional
training needs.  
Examples provided in the book
detail many innovations relevant to
delivering health services, particularly
for providing access for poor and mar-
ginalized persons. However, the
examples do not provide an analysis
of different experiences across coun-
tries and systems. Veterinary services
have evolved and should respond to
social, economic, and political reali-
ties. Guidance should be provided to
the decision makers who want an
analysis of what works under different
circumstances. 
From an infectious disease per-
spective, the focus is on promoting
livestock production and trade, with
less emphasis on public health and
food safety issues. This emphasis is
consistent with current veterinary pol-
icy and practice in most developing
countries, where economic develop-
ment is more relevant than public
health concerns. The World
Organisation for Animal Health,
which is responsible for international
animal and animal product trade stan-
dards under the World Trade
Organisation, also focuses on this
perspective. 
The book reflects the constraints
and broad mandates of veterinary
services in developing countries and
the potential short-term conflicts of
interests between livestock commerce
and public health. However, the book
does not address links between veteri-
nary and public health services,
including common surveillance,
information, and disease control sys-
tems. Because the book highlights the
veterinary components of disease
control systems, it provides an impor-
tant resource to develop such systems
in the future. 
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